AC Immune SA (NASDAQ:ACIU) traded at $2.75 at close of the session on Friday, April 05, remained unchanged from its previous day’s price.
Looking at the stock we see that its previous close was $2.75 and the beta (5Y monthly) reads 1.02 . In terms of its 52-week price range, ACIU has a high of $5.14 and a low of $1.78. The company’s stock has lost about -29.12% over that past 30 days.
AC Immune SA has a market cap of $272.80 million and is expected to release its quarterly earnings report on Mar 11, 2024 – Mar 15, 2024. Estimates by analysts give the company expected earnings per share (EPS) of -$0.11, with the EPS growth for the year raised at -$0.72 for 2024 and -$0.07 for next year. These figures represent -1.40% and 90.30% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $9.03 million, with a low of $1.11 million and a high of $16.96 million. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $14.02 million, or -14.60% down from figures reported last year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ACIU stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is -14.27% off its SMA20 and -15.95% from its 50-day simple moving average. The RSI (14) is pointing at 37.19 while the volatility over the past week is 7.65% and jumps to 9.47% over the past one month. The beta value is 1.02, while the average true range (ATR) is currently pointing at 0.28.
Coming back to AC Immune SA (NASDAQ:ACIU), we note that the average 3-month trading volume was 145.88K, while that of the preceding 10-day period stands at 0.35 million. Current shares outstanding are 99.20 million.
The insiders hold 42.45% of the company’s shares while institutions hold 30.59%. The data shows that short shares as of Mar 15, 2024, stood at 0.58 million at a short ratio of 4.72. This represents a 0.59% short interest in shares outstanding on Mar 15, 2024. Shares short fall in March from the previous month at 0.67 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -45.00% down in year-to-date price movement.
